Manher Joshi

Chief Development Officer at Soleno Therapeutics · 3 reported transactions in 1 company · latest report May 18, 2026

Their trades


Soleno TherapeuticsSLNO	Returned to company — · 20,171 shares	May 18, 2026
Soleno TherapeuticsSLNO	Share award — · 4,100 shares	Jan 21, 2026
Soleno TherapeuticsSLNO	Share award — · 16,071 shares	Nov 10, 2025

Returned to companySoleno Therapeutics

May 18, 2026 · SLNO

20,171

Share awardSoleno Therapeutics

Jan 21, 2026 · SLNO

4,100

Share awardSoleno Therapeutics

Nov 10, 2025 · SLNO

16,071

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.